SOUTH
SAN FRANCISCO, California and VANCOUVER, Canada, May 11, 2023
/CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX),
a clinical-stage pharmaceutical company focused on developing novel
therapies for the treatment of prostate cancer, today announced
that the Company will be presenting at the JMP Securities Life
Sciences Conference on Tuesday, May 16,
2023 at 10:00 a.m. Eastern
Time in New York.
David R. Parkinson, President and
Chief Executive Officer of ESSA Pharma; Peter Virsik, ESSA's Chief Operating Officer;
and David S. Wood, ESSA's Chief
Financial Officer, will host and participate in one-on-one
meetings.
A live webcast of the JMP Securities presentation can be
accessed in the Investors/Events & Presentations section of
ESSA's website at www.essapharma.com. Following the event, the
webcast will be archived on the ESSA website for 90 days.
About ESSA Pharma Inc.
ESSA is a clinical-stage pharmaceutical company focused on
developing novel and proprietary therapies for the treatment of
patients with prostate cancer. For more information, please visit
www.essapharma.com and follow us on Twitter under
@ESSAPharma.
View original
content:https://www.prnewswire.com/news-releases/essa-pharma-to-present-at-jmp-securities-life-sciences-conference-301821736.html
SOURCE ESSA Pharma Inc